Government
PRODUCTS
-
Polyzen is an innovative developer and manufacturer of polymer films, membranes, and laminates for a broad range of medical and non-medical applications. We specialize in single and multilayer extruded films in various sizes, thicknesses, and material formulations. Our in-house film extrusion capabilities include material formulation, film prototyping, film production, testing, inspection, validation, assembly, and logistics management. Combined with our extensive knowledge of medical device quality and regulation standards, Polyzen has become a trusted film supplier to medical device OEMs worldwide.
-
Your one-stop shop for repair requests, contracts, maintenance, and service history.
-
A unified platform connects teams, digitizes workflows, and delivers real-time insights to speed study startup, strengthen oversight, and keep trials inspection-ready end to end.
-
With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support, accelerating your path to the clinic and beyond.
-
DIANT Pharma provides continuous manufacturing systems and technical services for nanoparticle-based formulations. The company’s platform supports both research and manufacturing teams working on lipid nanoparticles (LNPs), liposomes, polymeric micelles, nucleic acid–lipid complexes, and other colloidal systems.
WHITE PAPERS AND CASE STUDIES
-
DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS
How does the DECODE CRS Coalition help trial sponsors standardize protocols and build a first-of-its-kind wearable dataset to lower development costs and safely de-risk outpatient care?
-
Developing Effective Procedures
Effective procedure development starts with understanding the purpose and should integrate change management, risk management, and knowledge management to ensure a robust quality system.
-
2026 State Of Clinical Trial Technology: The Five Strategic Imperatives
AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.
-
Avoiding The Pitfalls Of APQR
Traditional quality reviews often fall short in today’s data-heavy environment. A real-time, digital-first approach enables faster insights, stronger compliance, and more proactive quality management.
-
City Of Westminster, Colorado, And The Value Of Trustworthy Data
This case study explores how the City of Westminster in Colorado has implemented a new mobile app, Trimble Unity Mobile for Cityworks, to streamline workflows and reduce manual data entry for water utility crews.
-
Don't Let Formulation Failures Derail Drug Development
In the face of increasing molecular complexity, early developability assessment with a skilled CDMO can reduce pharmaceutical development costs, prevent clinical delays, and improve commercial success.
-
Compound Library Consortium
Explore how a novel approach to enhancing drug discovery efforts can significantly improve the chances of identifying promising drug candidates, ultimately accelerating the path from discovery to development.
-
Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories
Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.
-
World's Largest 1,4-Dioxane Treatment Initiative
Groundwater on Long Island, New York, contains the contaminant 1,4-dioxane. Despite no federal regulation, local water providers and state authorities have taken action to address contamination, establishing a state-enforced maximum contaminant level.
-
Successful SwissMedic Marketing Authorization Application For An Oncology Therapy
See how strategic EU dossier adaptation and Swiss-specific regulatory expertise enabled a successful SwissMedic submission and accelerated market access for an oncology therapy.
-
AMERICAN Plays A Role In Rebuilding Puerto Rico's Infrastructure
AMERICAN is helping rebuild Puerto Rico’s vital water infrastructure after Hurricane Maria, supplying American-made products to strengthen resiliency for 3.5 million residents and millions of annual visitors.
-
From Open Cleanrooms To Closed Systems – What Is Driving The Change?
Aseptic processing is evolving. Regulatory changes and technological advancements are driving a shift from open cleanrooms to closed systems for sterile drug manufacturing.
NEWS
-
CAI Secures NASPO ValuePoint® Master Agreement For Cloud And Software Solutions3/4/2026
CAI, a global services firm, and NASPO ValuePoint®, the cooperative purchasing division of the National Association of State Procurement Officials (NASPO), joined forces to help state and local governments adopt AI-enabled and emerging technologies faster without the delays of traditional procurement cycles.
-
Water-AI Nexus Welcomes Global Organizations To Advisory Council5/6/2026
The Water Environment Federation (WEF), alongside founding leaders Amazon, Leading Utilities of the World, and the Water Center at Penn, today announced a major expansion of the Water-AI Nexus Center of Excellence Advisory Council, strengthening cross-sector collaboration at the intersection of water and artificial intelligence.
-
BEINCOURT Awarded Texas Department Of Information Resources Contract Through Carahsoft5/22/2025
BEINCOURT, an innovative virtual and hybrid courtroom solutions developer, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced that BEINCOURT has been named as a reseller to the Texas Department of Information Resources (DIR) contract through Carahsoft.
-
Quantoom Biosciences Appoints Soter Bio As Exclusive North America RNA CDMO For RUO And GMP Manufacturing2/9/2026
Quantoom Biosciences, a leader in integrated RNA-LNP manufacturing technologies, today announced Soter Bio as its exclusive RNA Contract Development and Manufacturing Organization (CDMO) for both Research Use Only (RUO) and GMP manufacturing across North America, including the United States, Canada, and Mexico.
-
Lunai Bioworks Inc. Unveils Transformer Platform To Secure Generative AI And Accelerate Drug Discovery9/9/2025
Lunai Bioworks Inc., an AI-powered drug discovery and biodefense company, today announced the launch of a transformer-based platform that embeds biological risk intelligence directly into large language model (LLM) pipelines.